28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 10600 - 10800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
hl7.fhir.us.physical-activity | R4 | pa-diagnosticreport-type | PA DiagnosticReport Types | trial-use | 2 | pc | 2024-03 | us | hl7 | fhir loinc |
hl7.fhir.us.physical-activity | R4 | pa-servicerequest-code | PA ServiceRequest Intervention Codes | trial-use | 2 | pc | 2024-03 | us | hl7 | sct |
hl7.fhir.uv.recon-ig | R5 | apix-submission-type | APIX Submission Type Value Set | draft | 2025-07 | uv | hl7 | |||
hl7.fhir.uv.vhdir | R4 | consent | VhDir Consent Value Set | trial-use | 2 | pa | 2018-02 | uv | hl7 | fhir tho |
hl7.fhir.us.directory-query | R4 | ConsentVS | National Directory Consent Value Set | active | 2022-12 | us | hl7 | fhir | ||
hl7.fhir.us.directory-attestation | R4 | ConsentVS | NatDir Consent Scopes Valueset | active | 2022-12 | us | hl7 | fhir | ||
hl7.fhir.uv.ebm | R6 | research-study-document-types | Research Study Document Types Value Set | trial-use | 1 | cds | 2025-07 | uv | hl7 | fhir |
hl7.fhir.uv.ebm | R6 | search-strategy-characteristic | Search Strategy Characteristic Value Set | trial-use | 1 | cds | 2025-07 | uv | hl7 | fhir |
hl7.terminology | R5 | mif-conceptRelationshipReflexivity | MIF Concept Relationship Reflexivity | draft | 2025-07 | uv | hl7 | tho | ||
hl7.terminology | R5 | mif-conceptRelationshipKind | MIF Concept Relationship Kind | draft | 2025-07 | uv | hl7 | tho | ||
hl7.terminology | R5 | mif-conceptRelationshipSymmetry | MIF Concept Relationship Symmetry | draft | 2025-07 | uv | hl7 | tho | ||
hl7.terminology | R5 | mif-conceptRelationshipTransitivity | MIF Concept Relationship Transitivity | draft | 2025-07 | uv | hl7 | tho | ||
hl7.fhir.be.mycarenet | R4 | eagreementadjudicationreason | ValueSet adjudication reason | trial-use | 1 | fhir | 2025-06 | be | hl7 | internal |
hl7.fhir.be.terminology | R4 | eagreementadjudicationreason | ValueSet adjudication reason | trial-use | 1 | fhir | 2025-02 | be | hl7 | internal |
hl7.fhir.be.mycarenet | R4 | eagreementmessage | ValueSet message | trial-use | 1 | fhir | 2025-06 | be | hl7 | internal fhir |
hl7.fhir.be.terminology | R4 | eagreementmessage | ValueSet message | trial-use | 1 | fhir | 2025-02 | be | hl7 | internal fhir |
hl7.fhir.uv.ebm | R6 | recommendation-justification-classifier | Recommendation Justification Classifier Codes Value Set | trial-use | 1 | cds | 2025-07 | uv | hl7 | |
hl7.fhir.uv.ebm | R6 | evidence-rating-system-classifier | Evidence Rating System Classifier Codes Value Set | trial-use | 1 | cds | 2025-07 | uv | hl7 | fhir |
hl7.fhir.us.ndh | R4 | NdhVerificationStatusVS | NDH Verification Status Value Set | trial-use | pa | 2025-07 | us | hl7 | fhir | |
hl7.fhir.us.ndh | R4 | VirtualModalitiesVS | Virtual Modalities Value Set | trial-use | pa | 2025-07 | us | hl7 | tho | |
hl7.fhir.us.directory-query | R4 | VirtualModalitiesVS | Virtual Modalities Value Set | active | 2022-12 | us | hl7 | fhir | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | VirtualModalitiesVS | Virtual Modalities VS | trial-use | fm | 2025-02 | us | hl7 | fhir | |
kl.dk.fhir.ffinst | R4 | FindingInformerCodes | FindingInformerCodes | active | 2023-08 | dk | internal | |||
kl.dk.fhir.children | R4 | FindingInformerCodes | KildeTilOplysningKoder | active | 2024-10 | dk | ||||
hl7.terminology | R5 | research-study-reason-stopped | ResearchStudyReasonStopped | draft | 1 | brr | 2020-02 | uv | hl7 | tho |
botswana.hie.fhir | R5 | vs-master-facility-list-codes | Master Facility List (MFL) Codes | active | 2025-05 | internal | ||||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-certainty-of-evidence | Rating Certainty Of Evidence | draft | 2022-09 | uv | hl7 | fhir | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-concern-degree | Rating Concern Degree | draft | 2022-09 | uv | hl7 | fhir | ||
hl7.fhir.us.spl | R5 | valueset-splColor | SPL Color | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splComboProductType | SPL Combo Product Type | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splDoseForm | SPL Dose Form | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splFlavor | SPL Flavor | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splMarketingCategories | SPL Marketing Categories | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splOperationType | SPL Operation Type | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splPackageTypes | SPL Package Types | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splRouteOfAdministration | SPL Route of Administration | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splShape | SPL Shape | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splSpecialMeasures | SPL Special Measures | trial-use | 1 | brr | 2025-07 | us | hl7 | ncit |
il.core.fhir.r4 | R4 | reason-not-done | statusReason codes for Immunization profile | active | 2025-03 | il | national | sct | ||
il.core.fhir.r4 | R4 | immunization-side-effect | Immunization side-effect codes | active | 2025-03 | il | national | sct | ||
vcds-ig.euvabeco.net | R5 | NUVA | NUVA codes | draft | 2025-05 | internal | ||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-tnm-m-kategorie | MII VS Onkologie TNM M Kategorie | active | de | sct | ||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-tnm-n-kategorie | MII VS Onkologie TNM N Kategorie | active | de | sct | ||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-tnm-t-kategorie | MII VS Onkologie TNM T Kategorie | active | de | sct | ||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-grading | MII VS Onkologie Grading | active | de | |||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-primaertumor-diagnosesicherung | MII VS Onkologie Primärtumor Diagnosesicherung | active | de | |||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-seitenlokalisation | MII VS Onkologie Primärtumor Seitenlokalisation | active | de | |||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-tnm-version | MII VS Onkologie TNM Version | active | de | |||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-tnm-cp-praefix | MII VS Onkologie TNM cpu Praefix | active | de | |||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-tnm-klassifikation-typ | MII VS Onkologie TNM Klassifikation Typ | active | de | sct | ||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-icdo3-topographie | MII VS Onkologie ICD-O-3 Topographie | active | de | tho | ||||
kbv.ita.aws | R4 | KBV_VS_AW_Vermittlungsart | KBV_VS_AW_Vermittlungsart | active | 2018-10 | |||||
de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | mii-vs-onko-icdo3-morphologie | MII VS Onkologie ICD-O-3 Morphologie | active | de | tho | ||||
hl7.eu.fhir.idea4rc | R4 | coded-test-results-athena-vs | Coded test results: Athena. | draft | 2025-07 | eu | hl7 | internal | ||
hl7.eu.fhir.idea4rc | R4 | cancer-histology-behavior-athena-vs | Cancer histology behaviour: Athena | draft | 2025-07 | eu | hl7 | internal | ||
hl7.eu.fhir.idea4rc | R4 | cancer-histology-subgroup-athena-vs | Cancer histology subgroup: Athena | draft | 2025-07 | eu | hl7 | internal | ||
hl7.fhir.uv.saner | R4 | AllCOVID19RiskFactors | All COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | COPDCOVID19RiskFactors | COPD COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | CardiovascularCOVID19RiskFactors | Cardiovascular COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | KidneyDiseaseCOVID19RiskFactors | Kidney Disease COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | DiabetesCOVID19RiskFactors | Diabetes COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | HypertensionCOVID19RiskFactors | Hypertension COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | NeoplasticCOVID19RiskFactors | Neoplastic COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | ObesityCOVID19RiskFactors | Obesity COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | PregnancyCOVID19RiskFactors | Pregnancy COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | SickleCellCOVID19RiskFactors | Sickle Cell COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | TobaccoCOVID19RiskFactors | Tobacco COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | COVID19Complications | COVID-19 Complications | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.uv.saner | R4 | VTEReports | Codes for reports about VTE Diagnosics | active | pher | 2024-05 | uv | hl7 | loinc | |
hl7.fhir.uv.saner | R4 | IsolationPrecautions | COVID-19 Isolation Precautions | active | pher | 2024-05 | uv | hl7 | sct | |
hl7.fhir.us.davinci-crd | R4 | cdsHookType | CDS Hook Types Value Set | trial-use | 4 | fm | 2025-07 | us | hl7 | fhir |
hl7.terminology | R5 | parameter-group | DeviceDefinitionParameterGroup | draft | oo | 2020-02 | uv | hl7 | tho | |
hl7.terminology | R5 | v3-NationEntityType | NationEntityType | active | 2014-03 | uv | hl7 | tho | ||
hl7.fhir.uv.saner | R4 | SuspectedOrConfirmedCOVID19Diagnoses | Suspected Or Diagnosed COVID-19 | active | pher | 2024-05 | uv | hl7 | sct icd | |
hl7.eu.fhir.idea4rc | R4 | HNC-condition-athena-vs | HNC ConditionList: Athena | draft | 2025-07 | eu | hl7 | |||
hl7.eu.fhir.idea4rc | R4 | cancer-diagnosis-athena-vs | Cancer Diagnosis: Athena | draft | 2025-07 | eu | hl7 | internal | ||
hl7.eu.fhir.idea4rc | R4 | sarcome-list-athena-vs | Sarcome List: Athena | draft | 2025-07 | eu | hl7 | |||
hl7.eu.fhir.idea4rc | R4 | cancer-histology-athena-vs | Cancer histology: Athena | draft | 2025-07 | eu | hl7 | internal | ||
signal.core.r4 | R4 | chargeitem-status | ChargeItemStatus | trial-use | 0 | pa | 2019-10 | us | hl7 | fhir |
hl7.terminology | R5 | definition-status | DefinitionStatus | draft | fhir | 2020-02 | uv | hl7 | tho | |
signal.core.r4 | R4 | invoice-status | InvoiceStatus | trial-use | 0 | fm | 2019-10 | us | hl7 | fhir |
hl7.fhir.uv.ae-research-backport-ig | R4 | adverse-event-status-vs | Adverse Event Status | informative | brr | 2024-04 | uv | hl7 | fhir | |
signal.core.r4 | R4 | event-status | EventStatus | trial-use | 3 | fhir | 2019-10 | us | hl7 | fhir |
signal.core.r4 | R4 | request-status | RequestStatus | draft | 3 | pc | 2019-10 | us | hl7 | fhir |
hl7.eu.fhir.idea4rc | R4 | cancer-event-type-vs | Disease Status: Athena | draft | 2025-07 | eu | hl7 | internal | ||
hl7.eu.fhir.idea4rc | R4 | metastasis-disorder-athena-vs | Metastatis: Athena | draft | 2025-07 | eu | hl7 | |||
hl7.fhir.us.mcode | R4 | mcode-neuroblastoma-inss-value-vs | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set | active | cic | 2025-02 | us | hl7 | sct | |
hl7.fhir.us.mcode | R4 | mcode-myeloma-iss-stage-value-vs | International Staging System (ISS) for Myeloma Stage Value Set | active | cic | 2025-02 | us | hl7 | ncit | |
hl7.fhir.us.mcode | R4 | mcode-myeloma-riss-stage-value-vs | Revised International Staging System (ISS) for Multiple Myeloma Stage Value Set | active | cic | 2025-02 | us | hl7 | ncit | |
hl7.fhir.us.mcode | R4 | mcode-all-risk-assessment-value-vs | Acute Lymphoblastic Leukemia (ALL) Risk Assessment Value Set | active | cic | 2025-02 | us | hl7 | ncit | |
hl7.fhir.us.mcode | R4 | mcode-binet-stage-value-vs | Binet Stage Value Set | active | cic | 2025-02 | us | hl7 | ncit | |
hl7.fhir.us.mcode | R4 | mcode-breslow-depth-stage-value-vs | Breslow Depth Stage Value Set | active | cic | 2025-02 | us | hl7 | sct | |
hl7.fhir.us.mcode | R4 | mcode-neuroblastoma-INRGSS-value-vs | International Neuroblastoma Risk Group Staging System (INRGSS) for Neuroblastoma Risk Assessment Value Set | active | cic | 2025-02 | us | hl7 | ncit | |
hl7.fhir.us.mcode | R4 | mcode-wilms-tumor-stage-value-vs | Wilms Tumor Stage Value Set | active | cic | 2025-02 | us | hl7 | sct | |
hl7.fhir.us.mcode | R4 | mcode-pretext-stage-value-vs | PRETEXT Stage Value | active | cic | 2025-02 | us | hl7 | ncit | |
hl7.fhir.us.mcode | R4 | mcode-rai-stage-value-vs | Rai Stage Value Set | active | cic | 2025-02 | us | hl7 | ncit | |
hl7.fhir.us.mcode | R4 | mcode-rhabdomyosarcoma-assessment-value-vs | Rhabdomyosarcoma Assessment Value Set | active | cic | 2025-02 | us | hl7 | ncit sct | |
hl7.fhir.us.mcode | R4 | mcode-international-retinoblastoma-stage-value-vs | International Retinoblastoma Stage Value | active | cic | 2025-02 | us | hl7 | ncit | |
ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-substance-admin-substitution-code | Substance Administration Substitution Codes | draft | 2025-01 | ch | hl7 | tho | ||
ca.on.phsd.r4-alpha | R4 | wait-time-range | Wait Time Range | draft | ||||||
hl7.fhir.us.pacio-adi | R4 | ADIPMOConsentCategoriesVS | Portable Medical Order Categories | trial-use | 2 | pe | 2025-07 | us | hl7 | tho |
hl7.fhir.us.pacio-adi | R4 | ADIAttesterRoleTypeVS | Attester Role | trial-use | 2 | pe | 2025-07 | us | hl7 | loinc |
hl7.fhir.us.physical-activity | R4 | pa-task-status | PA Task Fulfillment Status | trial-use | 2 | pc | 2024-03 | us | hl7 | fhir |
hl7.fhir.us.pacio-adi | R4 | ADIHCADecisionsVS | Healthcare Agent Decisions | trial-use | 2 | pe | 2025-07 | us | hl7 | fhir loinc |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) | active | 2008-01 | us | sct tho oid | |||
hl7.fhir.us.davinci-pct | R4 | PCTAdjustmentReasonVS | PCT Adjustment Reason | trial-use | fm | 2025-06 | us | hl7 | x12 | |
hl7.fhir.us.illTraveler | R4 | InfectiousDiseaseVS | Infectious Disease VS | draft | 2024-03 | us | hl7 | sct | ||
signal.core.r4 | R4 | request-intent | RequestIntent | draft | 3 | oo | 2019-10 | us | hl7 | fhir |
signal.core.r4 | R4 | invoice-priceComponentType | InvoicePriceComponentType | trial-use | 0 | fm | 2019-10 | us | hl7 | fhir |
hl7.fhir.us.mcode | R4 | mcode-wilms-tumor-body-site-vsCOG | Wilms Tumor Body Site Value Set | active | cic | 2025-02 | us | hl7 | sct | |
fhir.paciosampledata | R4 | MAPProblemPriorityVS | Medical Action Plan Problem Priority | draft | 2025-07 | us | hl7 | sct tho | ||
MyHIE.v4-test | R4 | value-set-task-business-status-my-core | ValueSetTaskBusinessStatus (MY Core) | active | 2023-07 | |||||
IdHIE.0v | R4 | value-set-task-business-status-id-core | ValueSetTaskBusinessStatus (ID Core) | active | 2023-06 | |||||
uk.nhsdigital.r4.test | R4 | a6876ad9-6ac5-431a-980d-b093a07e84d6 | NHSDigital Task Code | draft | 2022-03 | hl7 | fhir | |||
hl7.terminology | R5 | payeetype | Payee Type Codes | active | 1 | fm | 2024-04 | uv | hl7 | tho |
hl7.fhir.us.mcode | R4 | mcode-deauville-scale-vs | Deauville Scale Value Set | active | cic | 2025-02 | us | hl7 | ncit | |
hl7.terminology | R5 | goal-acceptance-status | GoalAcceptanceStatus | draft | pc | 2020-02 | uv | hl7 | tho | |
hl7.fhir.cz.lab | R4 | cz-lab-clinically-relevant-time-VS | ValueSet - Clinically Relevant Time | active | 2025-07 | cz | hl7 | sct | ||
hl7.fhir.us.physical-activity | R4 | pa-observation-code-activity | PA Observation Activity-related codes | trial-use | 2 | pc | 2024-03 | us | hl7 | fhir loinc |
ca.on.oh-olis | R4 | olis-RequestPriority | RequestPriority | active | hl7 | fhir | ||||
hl7.fhir.us.core | R4 | us-core-observation-smoking-status-status | US Core Status for Smoking Status Observation | trial-use | 3 | cgp | 2022-09 | us | hl7 | fhir |
signal.core.r4 | R4 | observation-status | ObservationStatus | normative | 5 | oo | 2019-10 | us | hl7 | fhir |
hl7.terminology | R5 | variant-state | sequenceStatus | draft | cg | 2020-02 | uv | hl7 | tho | |
rapportendoscopiequebec.test | R4 | ca-qc-endo-valueset-impressionconclusionendo | ImpressionConclusionEndo | active | 2024-05 | |||||
hl7.terminology | R5 | v3-ActInvoiceAdjudicationPaymentCode | ActInvoiceAdjudicationPaymentCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-ActInvoiceAdjudicationPaymentSummaryCode | ActInvoiceAdjudicationPaymentSummaryCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.fhir.ca.baseline | R4 | ethnicitycode | EthnicityCode | draft | 2019-09 | ca | hl7 | sct | ||
hl7.terminology | R5 | v3-ActInvoiceDetailCode | ActInvoiceDetailCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-ActInvoiceAdjudicationPaymentGroupCode | ActInvoiceAdjudicationPaymentGroupCode | active | 2014-03 | uv | hl7 | tho | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.828 | Country | active | 2018-01 | us | iso tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.829 | County | active | 2019-01 | us | tho oid | |||
smart.who.int.anc | R4 | anc-b9-de165 | 75 g oral glucose tolerance test (OGTT) - 1 hour | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de166 | 75 g oral glucose tolerance test (OGTT) - 2 hours | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de164 | 75 g oral glucose tolerance test (OGTT) - fasting glucose | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de72 | Abdominal exam result - Abdominal exam result not done Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de74 | Abdominal exam result - Mass/tumour Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de73 | Abdominal exam result - Normal abdominal exam result Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de78 | Abdominal exam result - Other abnormal abdominal exam result (specify) Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de76 | Abdominal exam result - Pain on deep palpation Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de75 | Abdominal exam result - Pain on superficial palpation Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de77 | Abdominal exam result - Painful decompression Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de71 | Abdominal exam result | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b6-de58 | Allergies Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b6-de57 | Allergies | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de10 | Amniotic fluid level Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de9 | Amniotic fluid level | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de188 | Anaemia diagnosis Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de187 | Anaemia diagnosis | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-c-de5 | Any treatment given before referral | draft | 2025-06 | uv | who | |||
smart.who.int.anc | R4 | anc-b9-de157 | Asymptomatic bacteriuria (ASB) diagnosis Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de156 | Asymptomatic bacteriuria (ASB) diagnosis | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de15 | Average weight gain per week | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de4 | BMI | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-end-23 | Birth weight | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de160 | Blood glucose test ordered | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de168 | Blood glucose test result | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de162 | Blood glucose test type | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de175 | Blood haemoglobin test conducted | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de176 | Blood haemoglobin test ordered | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de186 | Blood haemoglobin test result | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de178 | Blood haemoglobin test type Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de177 | Blood haemoglobin test type | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de22 | Blood pressure cannot be taken | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de25 | Blood type Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de24 | Blood type | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b9-de22 | Blood type test conducted | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de34 | Body temperature | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de68 | Breast exam result - Bleeding Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de62 | Breast exam result - Breast exam not done Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de65 | Breast exam result - Discharge Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de66 | Breast exam result - Flushing Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de69 | Breast exam result - Increased temperature Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de67 | Breast exam result - Local pain Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de64 | Breast exam result - Nodule Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de63 | Breast exam result - Normal breast exam result Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de70 | Breast exam result - Other breast exam result (specify) Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de61 | Breast exam result | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de57 | Cardiac exam result - Arrhythmia Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de56 | Cardiac exam result - Bradycardia Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de51 | Cardiac exam result - Cardiac exam not done Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de59 | Cardiac exam result - Cold sweats Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de53 | Cardiac exam result - Heart murmur Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de52 | Cardiac exam result - Normal cardiac exam result Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de60 | Cardiac exam result - Other abnormal cardiac exam result (specify) Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de58 | Cardiac exam result - Peripheral cyanosis Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de55 | Cardiac exam result - Tachycardia Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de54 | Cardiac exam result - Weak pulse Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de50 | Cardiac exam result | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-end-41 | Cause of death Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-end-40 | Cause of death | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de93 | Cervical dilation | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de92 | Cervical exam conducted | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b8-de121 | Clinical enquiry for IPV | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b6-de145 | Clinical enquiry for alcohol and other substance use done | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-a-de14 | Co-habitants Choices | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-a-de13 | Co-habitants | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b6-de161 | Contraceptive use of female condoms | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b6-de160 | Contraceptive use of male condoms | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b10-de134 | Counsel to immediately go to the hospital if severe danger signs are present | draft | 2025-06 | uv | who | internal | ||
smart.who.int.anc | R4 | anc-b10-de78 | Counselling conducted on HIV positive | draft | 2025-06 | uv | who | internal |